Keratosis Actinic
Mostrando 1-12 de 20 artigos, teses e dissertações.
-
1. Cultural adaptation and validation of the quality of life questionnaire for patients with actinic keratosis (AKQoL-BR) to Brazilian Portuguese
Anais Brasileiros de Dermatologia. Publicado em: 2022
-
2. Prevalence of premalignant and malignant skin lesions in oculocutaneous albinism patients
SUMMARY OBJECTIVE: Oculocutaneous albinism describes a group of pigmentary disorders that lead to skin sensitivity and predisposition to skin malignances. Aims: To analyze clinical and epidemiological data in oculocutaneous albinism patients and to determine the prevalence of malignant skin lesions, assessing possible risk factors for skin cancer. METHODS
Rev. Assoc. Med. Bras.. Publicado em: 2021-01
-
3. Imiquimod/β-Cyclodextrin Inclusion Complex: Experimental and Theoretical Studies
Imiquimod (IMQ), an immune response modifier, is used for topical treatment of basal cell carcinoma and actinic keratosis. The very poor aqueous solubility of imiquimod gives rise to difficulties in designing aqueous formulations with this drug. One approach that is widely used to enhance drug solubility is complexation with cyclodextrins. The formation of t
J. Braz. Chem. Soc.. Publicado em: 2020-08
-
4. Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review,
Abstract Topical use of immune response modifiers, such as imiquimod, has increased in dermatology. Although its topical use is well tolerated, it may be associated with exacerbations of generalized cutaneous inflammatory diseases, possibly through the systemic circulation of pro-inflammatory cytokines. This report describes a case of development of pityrias
An. Bras. Dermatol.. Publicado em: 2020-02
-
5. Spiky follicular mycosis fungoides and hidradenitis suppurativa-like lesions in a patient - complete remission with interferon alpha,
Abstract Topical use of immune response modifiers, such as imiquimod, has increased in dermatology. Although its topical use is well tolerated, it may be associated with exacerbations of generalized cutaneous inflammatory diseases, possibly through the systemic circulation of pro-inflammatory cytokines. This report describes a case of development of pityrias
An. Bras. Dermatol.. Publicado em: 2020-02
-
6. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives
Abstract: Background: Actinic keratosis (AK) represents a risk of progression to squamous cell carcinoma. Ingenol mebutate gel is a novel therapeutic option for field-directed treatment. Objectives: To evaluate the safety, tolerability and patients' perspectives, related to the therapeutic success of managing AKs on the face and scalp with ingenol mebutate
An. Bras. Dermatol.. Publicado em: 29/07/2019
-
7. Dermatoses in parkinsonism: the importance of multidisciplinary follow-up
RESUMO Parkinsonismo é caracterizado por bradicinesia e/ou tremor de repouso, além de sintomas não motores, entre os quais se destacam as manifestações dermatológicas. O objetivo desse trabalho é conhecer as principais dermatoses em pacientes portadores de parkinsonismo atendidos em uma associação filantrópica de Curitiba/PR. Foi realizado um estud
Rev. Assoc. Med. Bras.. Publicado em: 22/07/2019
-
8. Estudo comparativo entre imagens de câmera fotográfica convencional e smartphone para o telediagnóstico de tumores palpebrais.
RESUMO Objetivo: comparar a acurácia do diagnóstico de tumor palpebral por avaliação de fotos obtidas por câmera convencional versus câmera acoplada em smartphone. Métodos: trinta e seis pacientes foram submetidos a exame externo e exame biomicroscópico para estabelecimento de diagnóstico clínico. As lesões foram fotografadas com câmera convenc
Rev. Col. Bras. Cir.. Publicado em: 07/03/2019
-
9. Vitamin D levels in actinic keratosis: a preliminary study
Abstract: Background: Recent studies that investigated the effect of vitamin D on skin cancer risk have exhibited inconsistent results. Objective: The aim of the study was to evaluate vitamin D status in patients with actinic keratosis. Methods: A cross-sectional study was conducted on 31 patients with actinic keratosis and 29 healthy controls. Serum vita
An. Bras. Dermatol.. Publicado em: 2018-08
-
10. Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
Abstract: Background: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil as a topical therapy for field cancerization in actinic ker
An. Bras. Dermatol.. Publicado em: 2018-08
-
11. Study of factors affecting the incidence of skin cancer in patients after liver transplant
Abstract: Background: Many factors are currently being identified as potential inductors of skin cancer in patients after a liver transplant, among them, immunosuppressive regimen. Objective: To study the factors that influence the incidence of skin cancer in patients after liver transplant. Methods: We have carried out a retrospective and observational s
An. Bras. Dermatol.. Publicado em: 2017-08
-
12. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors
Abstract: Background: Cancer is currently among the three leading causes of death after solid organ transplantation and its incidence is increasing. Non-melanoma skin cancer - squamous cell carcinoma and basal cell carcinoma - is the most common malignancy found in kidney transplant recipients (KTRs). The incidence of non-melanoma skin cancer in KTRs has no
An. Bras. Dermatol.. Publicado em: 2016-08